Skip to content
Screener

MiMedx Group MDXG Long-Term Debt

Long-Term Debt at other companies

IAR
Integra LifeSciencesIART
$1.74B+55.3%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$12.92M
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$56.15M-9.6%
Solventum logo
SolventumSOLV
$5.08B-35.0%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$19.65M-31.6%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$46.48M+5.1%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemJune 30,2026December 31,2025
Accrued expenses11,14011,383
Other current liabilities4,3905,790
Total current liabilities38,49864,266
Long term debt, net15,70616,467
Other liabilities10,7915,372
Total liabilities$64,995$86,105
Stockholders' equity
Common stock; $0.001 par value; 250,000,000 shares authorized; 149,188,840 issued and 145,724,441 outstanding at June 30, 2026 and 148,093,920 issued and outstanding at December 31, 2025149148

Item 1. Financial Statements

FAQ

What is MiMedx Group's long-term debt?
MiMedx Group (MDXG) reported long-term debt of $15.71M in Q2 2026.
How has MiMedx Group's long-term debt changed year-over-year?
MiMedx Group's long-term debt decreased by 8.7% year-over-year, from $17.21M to $15.71M.
What is the long-term trend for MiMedx Group's long-term debt?
Over 5 years (2020 to 2025), MiMedx Group's long-term debt has grown at a -19.2% compound annual growth rate (CAGR), from $47.7M to $16.47M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Ask your AI about MiMedx Group's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude